Chinook Therapeutics Inc.

NASDAQ: KDNY · Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM

Chinook Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
115.44M 181.72M
Short-Term Investments
262.89M 105.11M
Long-Term Investments
52.26M 117.62M
Other Long-Term Assets
9.4M 8.55M
Receivables
1.09M 10.06M
Inventory
n/a n/a
Other Current Assets
6.18M 3.74M
Total Current Assets
385.59M 300.64M
Property-Plant & Equipment
65.88M 74.32M
Goodwill & Intangibles
60.95M 62.68M
Total Long-Term Assets
188.49M 263.16M
Total Assets
574.08M 563.8M
Account Payables
9.75M 8.58M
Deferred Revenue
n/a 17.1M
Short-Term Debt
4.95M 4.4M
Other Current Liabilities
36.14M 10M
Total Current Liabilities
50.84M 40.09M
Long-Term Debt
34.49M 39.59M
Other Long-Term Liabilities
41.74M 29.75M
Total Long-Term Liabilities
81.31M 70.08M
Total Liabilities
132.14M 110.16M
Total Debt
39.44M 43.99M
Common Stock
7K 5K
Retained Earnings
-419.63M -231.77M
Comprehensive Income
-3.16M -55K
Shareholders Equity
441.94M 453.64M
Total Investments
315.15M 222.73M